SOOSAN CEBOTICS Statistics
Want to see KR:017550 full AI Analyst Report?
SOOSAN CEBOTICS (017550) Stock Statistics & Valuation Metrics
Total Valuation
SOOSAN CEBOTICS has a market cap or net worth of KRW 110.51B. The enterprise value is KRW 131.24B.
- Market Cap
- KRW 110.51B
- Enterprise Value
- KRW 131.24B
Share Statistics
SOOSAN CEBOTICS has 62,399,130 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 62,399,130
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
SOOSAN CEBOTICS’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 6.72%.
- Return on Equity (ROE)
- 0.08
- Return on Assets (ROA)
- 0.06
- Return on Invested Capital (ROIC)
- 6.72%
- Return on Capital Employed (ROCE)
- 0.09
- Revenue Per Employee
- 647.99M
- Profits Per Employee
- 44.75M
- Employee Count
- 354
- Asset Turnover
- 0.86
- Inventory Turnover
- 2.37
Valuation Ratios
The current PE Ratio of SOOSAN CEBOTICS is 5.84. SOOSAN CEBOTICS’s PEG ratio is 0.08.
- PE Ratio
- 5.84
- PS Ratio
- 0.44
- PB Ratio
- 0.52
- Price to FCF
- -6.42
- Price to Operating Cash Flow
- -13.57
- PEG Ratio
- 0.08
Income Statement
In the last 12 months, SOOSAN CEBOTICS had revenue of 229.39B and earned 15.84B in profits. Earnings per share was 253.85.
- Revenue
- 229.39B
- Gross Profit
- 51.65B
- Operating Income
- 19.01B
- Pretax Income
- 18.66B
- Net Income
- 15.84B
- EBITDA
- 25.09B
- Earnings Per Share (EPS)
- 253.85
Cash Flow
In the last 12 months, operating cash flow was -7.99B and capital expenditures -8.90B, giving a free cash flow of -16.89B billion.
- Operating Cash Flow
- -7.99B
- Free Cash Flow
- -16.89B
- Free Cash Flow per Share
- -270.68
Dividends & Yields
SOOSAN CEBOTICS pays an annual dividend of ―, resulting in a dividend yield of 0.56%
- Dividend Per Share
- ―
- Dividend Yield
- 0.56%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -15.18%
- Earnings Yield
- 16.67%
Stock Price Statistics
- Beta
- 0.44
- 52-Week Price Change
- 5.01%
- 50-Day Moving Average
- 1787.92
- 200-Day Moving Average
- 2096.43
- Relative Strength Index (RSI)
- 53.51
- Average Volume (3m)
- 240.05K
Important Dates
SOOSAN CEBOTICS upcoming earnings date is Nov 18, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 14, 2026
- Next Earnings Date
- Nov 18, 2026
- Ex-Dividend Date
- ―
Financial Position
SOOSAN CEBOTICS as a current ratio of 2.29, with Debt / Equity ratio of 18.60%
- Current Ratio
- 2.29
- Quick Ratio
- 1.11
- Debt to Market Cap
- 0.34
- Net Debt to EBITDA
- 1.48
- Interest Coverage Ratio
- 16.58
Taxes
In the past 12 months, SOOSAN CEBOTICS has paid 2.82B in taxes.
- Income Tax
- 2.82B
- Effective Tax Rate
- 0.15
Enterprise Valuation
SOOSAN CEBOTICS EV to EBITDA ratio is 8.93, with an EV/FCF ratio of -9.82.
- EV to Sales
- 0.68
- EV to EBITDA
- 8.93
- EV to Free Cash Flow
- -9.82
- EV to Operating Cash Flow
- -20.76
Balance Sheet
SOOSAN CEBOTICS has KRW 37.64B in cash and marketable securities with KRW 54.63B in debt, giving a net cash position of -KRW 16.99B billion.
- Cash & Marketable Securities
- KRW 37.64B
- Total Debt
- KRW 54.63B
- Net Cash
- -KRW 16.99B
- Net Cash Per Share
- -KRW 272.23
- Tangible Book Value Per Share
- KRW 3,057.18
Margins
Gross margin is 21.70%, with operating margin of 7.99%, and net profit margin of 7.57%.
- Gross Margin
- 21.70%
- Operating Margin
- 7.99%
- Pretax Margin
- 9.09%
- Net Profit Margin
- 7.57%
- EBITDA Margin
- 7.58%
- EBIT Margin
- 4.93%
Analyst Forecast
The average price target for SOOSAN CEBOTICS is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 16.56%
- EPS Growth Forecast
- 71.44%
Scores
- Smart Score
- ―
- AI Score
- 58
